Qiong Shen

机构：Donghua University, Suzhou Municipal Hospital · ORCID：0000-0001-6313-3642

发表论文 162 篇 · 总被引 10091 次 · h-index 36

代表论文

• XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 35)
• Prediction of MASLD using different screening indexes in Chinese type 2 diabetes mellitus (2025 · Diabetology & Metabolic Syndrome · 被引 19)
• Lobetyolin, a Q-marker isolated from Radix Platycodi, exerts protective effects on cisplatin-induced cytotoxicity in HEK293 cells (2023 · Journal of Natural Medicines · 被引 11)
• Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance (2024 · Leukemia · 被引 10)
• MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis (2024 · Nature Communications · 被引 8)
• Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues (2024 · Cancer Control · 被引 8)